Kenson Ventures

Kenson Ventures seeks to attain superior returns by investing in and advising early-stage, mid-stage, and some late-stage companies with great potential in the biotechnology and life sciences space. We help build values and companies. Kenson’s biomedical investments focus on molecular tools, diagnostics, and therapeutics. The company prides itself on identifying and partnering with strong, capable management teams operating in niche markets where differentiation, chosen strategies, and excellence in execution are keys. A significant percentage of Kenson-backed companies have achieved successful liquidity through mergers and acquisitions, demonstrating the effectiveness of its approach in selecting the right teams for delivering optimal results.